PDE4-IN-13 is a PDE4 inhibitor with an IC50 of 1.56 µM. PDE4-IN-13 shows anti-inflammatory and antioxidant properties, and can be used for chronic obstructive pulmonary disease (COPD) research[1].
Molecular Weight:
340.37
Formula:
C20H20O5
Target:
Phosphodiesterase (PDE)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
